Biomarin Pharmaceutical (BMRN) Net Margin (QoQ) (2009 - 2026)

Biomarin Pharmaceutical (BMRN) Net Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Biomarin Pharmaceutical 11.33 Bn 9.11 Bn 571.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,910.00
Dec 31, 2025 -136.00
Sep 30, 2025 -3,310.00
Jun 30, 2025 422.00
Mar 31, 2025 820.00
Dec 31, 2024 249.00
Sep 30, 2024 -83.00
Jun 30, 2024 139.00
Mar 31, 2024 1,051.00
Dec 31, 2023 -379.00
Sep 30, 2023 -247.00
Jun 30, 2023 89.00
Mar 31, 2023 857.00
Dec 31, 2022 127.00
Sep 30, 2022 -650.00
Jun 30, 2022 -1,808.00
Mar 31, 2022 3,613.00
Dec 31, 2021 -394.00
Sep 30, 2021 -1,151.00
Jun 30, 2021 -99.00